RIKEN TECHNOS CORPORATION
4220・Prime Market・Chemicals
Daily Life & Healthcare
Segment offering high value-added products for the medical, daily living materials, and food packaging materials markets
| Period | Current | Previous | Change |
|---|---|---|---|
| Revenue (FY2026 (ending March 2026), full year) | ¥36,474 million | ¥36,809 million | ↓ |
| Segment Profit (FY2026 (ending March 2026), full year) | ¥3,941 million | ¥3,522 million | ↑ |
| Segment Assets (FY2026 (ending March 2026), full year) | ¥12,879 million | ¥12,688 million | ↑ |
| Depreciation (FY2026 (ending March 2026), full year) | ¥799 million | ¥796 million | — |
| Capital Expenditures (increase in tangible/intangible fixed assets, FY2026 (ending March 2026) full year) | ¥1,111 million | ¥444 million | ↑ |
| Segment Profit Margin (FY2026 (ending March 2026), full year) | 10.8% | 9.6% | ↑ |
Business Details
Targets the medical, daily living materials, and food packaging materials markets, manufacturing and selling Compound, Film, and Food Packaging Materials. Domestically, focus is on PVC Compound (for Daily Living Materials) and household wrap/film products, while overseas efforts center on expanding sales of PVC Compound (for Medical & Daily Living Materials) primarily in ASEAN. The segment is pursuing global expansion utilizing domestic and overseas sites such as Riken Food Packaging (Jiangsu) Co., Ltd., and under the medium-term management plan "One Vision, New Stage 2027," aims to expand high value-added products in the medical/healthcare and daily living materials fields while pursuing new business areas.
Recent Overview
Revenue declined but margin improved, with expanded ASEAN medical sales driving profit growth
In FY2026 (ending March 2026), revenue was ¥36,474 million (down 0.9% year on year), a slight decrease. Domestically, while PVC Compound (for Daily Living Materials) remained solid, declines in household wrap and film sales weighed on results. Overseas, sales of PVC Compound to the US and China markets declined, contributing to the revenue decrease. Meanwhile, expanded sales of PVC Compound for the ASEAN medical market progressed, resulting in segment profit of ¥3,941 million (up 11.9% year on year), a substantial increase. Capital expenditures rose sharply to ¥1,111 million from ¥444 million in the prior period, reflecting ongoing investment aimed at expanding future production capacity.
Key Products
Growth Drivers
- Continued expansion of PVC Compound sales for overseas medical markets centered on ASEAN
- Improved profit margins through appropriate pricing (cost pass-through)
- Strengthened initiatives for the medical and food packaging materials markets under the new medium-term management plan "One Vision, New Stage 2027"
- Execution of sales strategy from a global perspective (including expansion to non-Japanese companies)
- Enhanced production capacity and future earnings contribution through expanded capital expenditures (approximately 2.5x year on year)
Risks
- Sluggish demand and declining sales trend in the domestic household wrap and film market
- Risk of fluctuation in domestic demand for PVC Compound (for Daily Living Materials)
- Rising manufacturing costs due to soaring raw material prices (PVC resin, etc.)
- Impact on demand in the US and China markets from China's economic slowdown and stagnant real estate market
- Foreign exchange risk (impact on earnings from overseas sites in ASEAN, China, etc.)
Last updated: June 10, 2026